FREE SHIPPING ON ORDERS OVER $150

metabolic acidosis and glutathione Unexplained in critically ill patients: the role of pyroglutamic acid | Intensive Care Medicine Glutathione synthetase deficiency | MedLink

$21.06

Quantity
- +
Description

[DOI] [PubMed] [Google Scholar] 156

metabolic acidosis and glutathione Unexplained in critically ill patients: the role of pyroglutamic acid | Intensive Care Medicine Glutathione synthetase deficiency | MedLink

Revonsuo A

metabolic acidosis and glutathione Unexplained in critically ill patients: the role of pyroglutamic acid | Intensive Care Medicine Glutathione synthetase deficiency | MedLink

The recent discovery of the small molecule N6F11, which binds the tripartite region of Trim25 and promotes proteasome-degradation of GPX4 in pancreatic cancer cells, while sparing immune cells and the anti-tumoral response of the microenvironment, could represent a major clinical breakthrough for the use of GPX4 inhibitor/degrader [61]

metabolic acidosis and glutathione Unexplained in critically ill patients: the role of pyroglutamic acid | Intensive Care Medicine Glutathione synthetase deficiency | MedLink

doi: 10.1155/2013/316523

metabolic acidosis and glutathione Unexplained in critically ill patients: the role of pyroglutamic acid | Intensive Care Medicine Glutathione synthetase deficiency | MedLink

For most people, that means a combination of lifestyle changes, nutritional support, and possibly even medical treatments that target the root cause

metabolic acidosis and glutathione Unexplained in critically ill patients: the role of pyroglutamic acid | Intensive Care Medicine Glutathione synthetase deficiency | MedLink

doi: 10.3390/nu13124397 264

metabolic acidosis and glutathione Unexplained in critically ill patients: the role of pyroglutamic acid | Intensive Care Medicine Glutathione synthetase deficiency | MedLink

You may also like

recommand products